Drugmaker Amgen lays off 300 U.S. employees

Updated: Jan 30, 2023, 13:21 UTC

(Reuters) - Amgen Inc said on Monday that it had let go about 300 employees based in the United States, mainly in its commercial team, citing recent organizational changes to better manage the company against "industry headwinds".

An Amgen sign is seen at the company's office in South San Francisco

(Reuters) -Drugmaker Amgen Inc said on Monday that it let go about 300 U.S. employees or about 1.2% of its total workforce, citing recent organizational changes to its commercial team.

The company had about 24,200 staff members in over 50 countries, as of December 31, 2021, according to its latest annual regulatory filing with the U.S. Securities and Exchange Commission.

Big Tech firms and Wall Street titans have led a string of layoffs across corporate America in recent weeks. Amgen’s move to trim its workforce shows how rapid interest rate hikes and a fading boom in demand post pandemic has begun to weigh on the healthcare sector.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Savio D’Souza and Rashmi Aich)

About the Author


Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at and via Reuters TV. Learn more about Thomson Reuters products:

Did you find this article useful?